Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2017

Aug 30, 2024

SELL
$4.5 - $5.77 $1,125 - $1,442
-250 Closed
0 $0
Q2 2017

Aug 30, 2024

SELL
N/A
-6,894 Reduced 96.5%
250 $1.5 Million
Q1 2017

Aug 30, 2024

BUY
N/A
7,144
7,144 $42.6 Million

Others Institutions Holding TRIB

# of Institutions
1
Shares Held
30.2K
Call Options Held
0
Put Options Held
0

About TRINITY BIOTECH PLC


  • Ticker TRIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 38,107,600
  • Market Cap $42.7M
  • Description
  • Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious dis...
More about TRIB
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.